Stonepine Capital Management, LLC Exagen Inc. Transaction History

Stonepine Capital Management, LLC

$158 Billion
Q3 2024

A detailed history of Stonepine Capital Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 534,398 shares of XGN stock, worth $2.68 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

534,398

Previous 358,697 48.98%

Holding current value

$2.68 Million

Previous $653 Million 152.94%

% of portfolio

1.04%

Previous 0.6%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.74 - $3.42 $305,719 - $600,897	175,701 Added 48.98%	534,398 $1.65 Billion
Q2 2024 Aug 13, 2024	SELL	$1.36 - $2.05 $35,228 - $53,101	-25,903 Reduced 6.74%	358,697 $653 Million
Q1 2024 May 14, 2024	SELL	$1.42 - $2.3 $404,819 - $655,693	-285,084 Reduced 42.57%	384,600 $612 Million
Q4 2023 Feb 13, 2024	SELL	$1.45 - $2.39 $774,020 - $1.28 Million	-533,807 Reduced 44.35%	669,684 $1.33 Billion
Q3 2023 Nov 13, 2023	BUY	$2.24 - $2.93 $2.7 Million - $3.53 Million	1,203,491 New	1,203,491 $2.91 Billion
Q2 2023 Aug 11, 2023	BUY	$2.36 - $3.48 $28,976 - $42,727	12,278 Added 1.18%	1,049,352 $3.04 Million
Q1 2023 May 12, 2023	BUY	$2.23 - $2.9 $408,161 - $530,792	183,032 Added 21.43%	1,037,074 $2.52 Million
Q4 2022 Feb 14, 2023	SELL	$2.1 - $3.4 $863,795 - $1.4 Million	-411,331 Reduced 32.51%	854,042 $2.05 Million
Q3 2022 Nov 10, 2022	BUY	$2.69 - $8.68 $13,412 - $43,278	4,986 Added 0.4%	1,265,373 $3.43 Million
Q2 2022 Aug 12, 2022	BUY	$4.18 - $7.74 $582,470 - $1.08 Million	139,347 Added 12.43%	1,260,387 $7.24 Million
Q1 2022 May 16, 2022	BUY	$7.12 - $11.06 $1.87 Million - $2.9 Million	262,473 Added 30.57%	1,121,040 $9 Million
Q4 2021 Feb 14, 2022	BUY	$8.97 - $14.08 $4.2 Million - $6.59 Million	467,930 Added 119.79%	858,567 $9.99 Million
Q3 2021 Nov 12, 2021	BUY	$10.25 - $15.21 $2.27 Million - $3.36 Million	221,095 Added 130.41%	390,637 $5.31 Million
Q2 2021 Aug 16, 2021	SELL	$12.4 - $17.92 $266,153 - $384,634	-21,464 Reduced 11.24%	169,542 $2.54 Million
Q1 2021 May 14, 2021	BUY	$13.9 - $22.0 $2.65 Million - $4.2 Million	191,006 New	191,006 $3.34 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

6.41M

Call Options Held

4.5K

Put Options Held

400

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $81.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Account

Stonepine Capital Management, LLC Exagen Inc. Transaction History